Pernell Jason 4

What Happened

• Jason Pernell, President of Trulieve Cannabis Corp., received equity awards on March 13, 2026: 58,594 restricted stock units (RSUs) and an additional 41,668 RSUs reported as derivative securities — a total of 100,262 RSUs. The awards were granted at $0.00 (no cash paid). These RSUs convert into subordinate voting shares upon vesting; 50% of the RSUs vest on December 1, 2027 and the remaining 50% on December 1, 2028. This is an award/grant (A), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-03-13; Filing date: 2026-03-17 (filed within the SEC’s 2-business-day deadline).
• Price: $0.00 reported (standard for RSU grants); total reported cash consideration = $0.
• Grants: 58,594 RSUs (direct) + 41,668 RSUs (derivative classification) = 100,262 RSUs total.
• Known ownership: Pernell is associated with trusts holding 22,635 and 22,636 Multiple Voting Shares (45,271 total), which are convertible into subordinate voting shares on a 1-for-100 basis (aggregate convertibility = 4,527,100 subordinate voting shares). He also holds previously granted options that vest in three annual installments (one-third on Dec 1 of 2026, 2027 and 2028).
• Notable footnotes: F1 explains the RSU vesting schedule; F2 details the multiple voting shares held via trusts and conversion ratio; F3 describes vesting schedule for certain options.
• Timeliness: Filing appears timely (filed Mar 17 for Mar 13 transaction).

Context

• RSU grants are compensation awards and do not require cash outlay; they convert to shares as they vest, so their ultimate value depends on Trulieve’s share price at vesting. This is an executive compensation action rather than an outright purchase (which some investors view as a stronger bullish signal). The presence of substantial convertible multiple voting shares indicates significant voting/investment control via trusts, but these grants themselves are standard compensation awards.